About Pacira Pharmaceuticals
Pacira Pharmaceuticals (NASDAQ:PCRX) specializes in non-opioid pain management and regenerative health solutions to improve patients' journeys in acute care and ambulatory settings. Traded on the NASDAQ stock exchange under the ticker code PCRX, the company focuses on pioneering projects aimed at minimizing reliance on opioids for post-surgical pain management. Pacira's flagship product, EXPAREL, exemplifies their commitment to providing innovative, effective pain relief options. With a keen eye on expanding its portfolio, Pacira actively pursues research and development projects alongside strategic acquisitions to broaden its impact on pain management. The overarching objective is to offer safer, more effective alternatives that can significantly alter patient care standards and better respond to the urgent need for opioid alternatives in medical practice.
Snapshot
Operations
Produtos e/ou serviços de Pacira Pharmaceuticals
- EXPAREL, a local anesthetic for postsurgical pain management.
- iovera°, a handheld device providing immediate and long-lasting pain relief through a novel cryoanalgesia technique.
- ZILRETTA, an extended-release corticosteroid injection for osteoarthritis knee pain.
- DepoFoam technology, a delivery system for sustained release of therapeutic agents.
- Nocita, a long-acting local anesthetic for post-surgical pain relief in pets.
- Pacira BioSciences Pipeline, focusing on developing innovative non-opioid pain management and regenerative health solutions.
equipe executiva do Pacira Pharmaceuticals
- Mr. Frank D. LeeCEO & Director
- Mr. Shawn M. CrossChief Financial Officer
- Ms. Lauren Bullaro RikerPrincipal Accounting Officer & Senior VP of Finance
- Ms. Kristen Williams Esq., J.D.Chief Administrative Officer & Secretary
- Dr. Jonathan Slonin M.D.Chief Medical Officer
- Ms. Susan MescoHead of Investor Relations
- Mr. Anthony Molloy III, Esq.Chief Legal & Compliance Officer
- Mr. Christopher C. YoungChief Manufacturing Officer
- Ms. Krys Corbett Esq.Chief Business Officer
- Mr. Brendan P. TeehanChief Commercial Officer